StrandSmart
About this raise
StrandSmart, with a valuation of $18.04 million, is raising funds on StartEngine. The company is developing a liquid biopsy test to identify the biological drivers of a tumor. The test also enables precision medicine that allows better matching of the right drug to the individual patient. StrandSmart enables physicians to extract cancer mutations from blood and augment the information by adding transcriptomic and proteomic data. The technology is currently in the pre-revenue stage, and the company is working with academics and pharma companies to validate the technology. Adrianna Davies founded StrandSmart in September 2017. The current crowdfunding campaign has a minimum target of $9,998.10 and a maximum target of $1.23 million. The campaign proceeds will be used for research and development and operations.
Investment Overview
Invested $35,873 :
Deal Terms
Company & Team
Company
- Year Founded
- 2017
- Industry
- Healthcare & Pharmaceuticals
- Tech Sector
- Distribution Model
- B2B
- Margin
- Medium
- Capital Intensity
- High
Financials
-
Revenue
-
$0
as of FY2021
- Monthly Burn
-
$98,643
as of FY2021
-
Runway
-
1.7 months
as of FY2021
Upgrade to gain access
-
$12.50 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific
Kingscrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual
Edge
Company Funding & Growth
Funding history
- Total Prior Capital Raised
- $5,981,700
- VC Backed?
- No
Close Date | Platform | Valuation | Total Raised | Security Type | Status | Reg Type |
---|---|---|---|---|---|---|
03/20/2023 | StartEngine | $18,040,050 | $35,873 | Equity - Common | Funded | RegCF |